Arkolith/Insider Trading/DNA/Form 4

Coen Steven P.

See remarksGinkgo Bioworks Holdings, Inc. (DNA) · full profile →Form 4 · filed Mar 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5K
Net Open-Market Flow
-$5K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2026Sell(S)708$6.74$5K9K
Mar 13, 2026Option exercise(M)1K——9K
Mar 13, 2026Option exercise(M)312——10K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 13, 2026Option exercise(M)312——4K
Mar 13, 2026Option exercise(M)1K——8K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-019475) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML